New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke (DMT)

telepathetic

telepathetic

Bluelighter
Joined
Jan 16, 2010
Messages
2,278
www.globenewswire.com

New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed

VANCOUVER, British Columbia, June 19, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the...
www.globenewswire.com www.globenewswire.com
Akome’s next generation psychedelic drug formulation for the mitigation of neurological damage resulting from ischemic strokes, also known as AKO001, is comprised of the psychedelic compound N,N-dimethyltryptamine (DMT) and a specific plant bioactive which, when combined together, are believed to work in a complementary and mitigating manner when provided to individuals immediately following their ischemic stroke. A provisional matter of composition patent application for AKO001 has been filed with the United States Patent and Trademark Office (USPTO) under application 63147343.
Click to expand...
 
Last edited by a moderator:
This isn't a patent on ayahuasca, but on the type of DMT which it produces. I'm going to clean up this presentation a litle for you @schizoinfective
 
pretty sure that the "specific plant bioactive" they are combining with the DMT is an MAOI, but totally conjecture. sounds like a patent on pharmahuasca though, i'd bet on it @Outlier
 
Last edited by a moderator:
schizoinfective said:
pretty sure that the "specific plant bioactive" they are combining with the DMT is an MAOI, but totally conjecture. sounds like a patent on pharmahuasca though, i'd bet on it @Outlier
Click to expand...
It is. Pharmahuasca isnt Ayahuasca though, as per the original thread title. Theres different steps involved although its the same active chemical.
 
You must log in or register to reply here.
Top